x 

0 Activities
0 Activities
    • No Saved Activities
Page 4 of 8
Results 181 - 240 of 460
No image set
Improved Patient Outcomes in PAH
9088-pfild-slides8
A New Paradigm in Treating ILD - Slide Deck
No image set
Principles of Management of Chronic GVHD
No image set
Diagnosing and Assessing Chronic Graft-versus-Host Disease
9101-chest
IPF Management and Antifibrotic Therapy
No image set
How to Develop an Effective Risk Reduction Strategy in Pulmonary Arterial Hypertension
No image set
Pulmonary Arterial Hypertension (PAH) - Therapy Options Explained
No image set
Updates in Duchenne Muscular Dystrophy: A Focus on Emerging Gene Therapy
No image set
EXPLORE Learning Experience: COVID-19 and Monoclonal Antibodies
No image set
EXPLORE Learning Experience: Understanding and Managing NTM-Lung Disease
No image set
Cardiac Amyloidosis: Is It A Zebra or A Horse? Webinar Summary Module
No image set
Cardiac Amyloidosis Webinar #4: Treatment of Cardiac Amyloidosis
No image set
Cardiac Amyloidosis Webinar #3: Establishing the Correct Diagnosis
No image set
Cardiac Amyloidosis Webinar #2: Cardiac Imaging Pearls
No image set
Cardiac Amyloidosis Webinar #1: Who Should I be Testing?
No image set
Updates in Diabetes Care for Primary Care Providers
No image set
Osteoporosis Updates: Primary Care’s Critical Role
No image set
Primary Care and Dyslipidemia: What Should You Do?
No image set
Staying Current in Obesity Management: Key Updates for Primary Care
No image set
Thyroid Assessment: Updates for Primary Care
No image set
A New Paradigm in Treating ILD
No image set
A Collaborative Approach to IPF Management
No image set
Practical Solutions to SSc-ILD Treatment
No image set
Post COVID-19 and Patients With and Without Pre-existing ILD
No image set
Exploring CGM: Achieving Treatment Goals Together
No image set
Reversing DOACS: Providing Answers to What, Where and How
No image set
How to Choose the Right Therapy for Your Patients with IPF
No image set
PAH: Aligning Treatment Strategy to Risk Level
No image set
PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes
No image set
LGMD: Mutation-specific Nomenclature
No image set
LGMD Symptomatology
No image set
LGMD Mutations and Disease Types
No image set
Tests and Outcomes - DMD
No image set
Genes, Exons, and the Pathophysiology of DMD
No image set
The Natural History of DMD
No image set
Reversing DOACS: Recording from Live Session held on July 18, 2021
No image set
Conquer the Clot: Addressing VTE in Your Patients with Cancer
No image set
Patient Develops de novo Features of ILD After a COVID Infection
No image set
SSc-ILD Individualized Treatment
No image set
Overlapping Symptoms and Risk Factors for COVID and IPF
No image set
Multidisciplinary Management of IPF
No image set
Fundamentals of Diagnosis: SSc-ILD
No image set
Fundamentals of Diagnosis: PF-ILD
No image set
Updates in SMA: Cure SMA Conference Coverage (CME/CE)
9076-0001-263x149
Healthcare Disparities in African Americans With Myeloma
No image set
New and Emerging Options for the Management of MS
No image set
Perioperative Nutrition and Wound Healing
No image set
Special Considerations for Nutrition for the Elderly
No image set
Diabetes & Nutrition
No image set
Comorbidities and Selection of DMTs
No image set
Itching for Relief: Atopic Dermatitis Management Considerations for PAs and NPs
No image set
IPF Management in Practice: A Truly Interactive Experience
No image set
Management of Breakthrough Disease Activity in MS
No image set
Highlights From the EAHAD 2021 Virtual Congress
No image set
Updated Follow-up of the Alta Study, Giroctocogene Fitelparvovec (SB-525)
No image set
First Data From the Phase 3 HOPE-B Gene Therapy Trial
No image set
The World Federation of Hemophilia Gene Therapy Registry
No image set
Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Pipe)
No image set
AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Leebeek)
No image set
AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Miesbach)
Page 4 of 8

Search